A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
Elocon
Synonyms :
Mometasone furoate
Class :
Topical steroids
Dosage Forms & StrengthsÂ
OintmentÂ
0.1%Â
CreamÂ
0.1%Â
LotionsÂ
0.1%Â
Dosage Forms & StrengthsÂ
OintmentÂ
0.1%Â
CreamÂ
0.1%Â
LotionsÂ
0.1%Â
Refer to adult dosingÂ
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
the anti-diabetic efficacy of acarbose can be reduced with mometasone furoate
the anti-diabetic efficacy of albiglutide can be reduced with mometasone furoate
the anti-diabetic efficacy of acetohexamide can be reduced with mometasone furoate
the anti-diabetic efficacy of bexagliflozin can be reduced with mometasone furoate
the anti-diabetic efficacy of canagliflozin can be reduced with mometasone furoate
the anti-diabetic efficacy of chlorpropamide can be reduced with mometasone furoate
the anti-diabetic efficacy of dapagliflozin can be reduced with mometasone furoate
the anti-diabetic efficacy of dulaglutide can be reduced with mometasone furoate
the anti-diabetic efficacy of empagliflozin can be reduced with mometasone furoate
the anti-diabetic efficacy of glimepiride can be reduced with mometasone furoate
the anti-diabetic efficacy of liraglutide can be reduced with mometasone furoate
the anti-diabetic efficacy of metformin can be reduced with mometasone furoate
the anti-diabetic efficacy of nateglinide can be reduced with mometasone furoate
the risk of adverse effects can be increased when omacetaxine is combined with mometasone furoate
the anti-diabetic efficacy of acarbose can be reduced with pramlintide furoate
the anti-diabetic efficacy of repaglinide can be reduced with mometasone furoate
the anti-diabetic efficacy of saxagliptin can be reduced with mometasone furoate
the anti-diabetic efficacy of tolbutamide can be reduced with mometasone furoate
the anti-diabetic efficacy of tolazamide can be reduced with mometasone furoate
may increase the risk or severity of toxic effects when combined
When mometasone furoate is used together with abatacept, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with acetylsalicylic acid, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with adalimumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with alefacept, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with alemtuzumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with altretamine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with anakinra, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with anifrolumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with apremilast, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with arsenic trioxide, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with avacopan, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with azacitidine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with baricitinib, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with basiliximab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with belatacept, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with belimumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with belinostat, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with belumosudil, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with bendamustine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with bexarotene, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with bleomycin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with blinatumomab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with brodalumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with budesonide, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with canakinumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with capecitabine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with carboplatin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with carmustine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with chloramphenicol, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with chlorambucil, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with cladribine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with clofarabine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with corticotropin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with cytarabine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with dacarbazine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with dactinomycin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with daunorubicin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with decitabine, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with denosumab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with deslanoside, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with dexamethasone, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with dexrazoxane, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with digitoxin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with digoxin, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together with dinutuximab, this leads to enhanced risk or seriousness of adverse outcomes
When mometasone furoate is used together in combination with profenamine, this leads to reduction in therapeutic effectiveness of profenamine
When mometasone furoate is aided by androstenediol, that promotes an increased risk of edema
Actions and spectrum:Â
Being a steroid, mometasone acts by inhibiting the activity of the chemicals that are responsible for inflammationÂ
Frequency not definedÂ
Thinning of skinÂ
ItchingÂ
BurningÂ
Blurred visionÂ
Eye painÂ
IrritationÂ
HeadacheÂ
Decreased visionÂ
Dry mouthÂ
AcneÂ
Cushing’s syndromeÂ
HypertrichosisÂ
Intracranial hypertensionÂ
Black Box WarningÂ
For external use only. Not intended for ophthalmic use Â
Do not use this drug on a child without the advice of the doctorÂ
Contraindication/Caution:Â
Contraindication:Â
DiabetesÂ
HypersensitivityÂ
Infection of skinÂ
Pregnancy consideration:Â Â
US FDA pregnancy category: CÂ
Lactation:Â Â
Limited data availableÂ
Note: cream should not be applied to the breasts of lactating mothersÂ
Pregnancy category:Â Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus `in either the first or second trimester.Â
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â
Limited data availableÂ
Pharmacodynamics:Â
Pharmacokinetics:Â
AbsorptionÂ
DistributionÂ
MetabolismÂ
Elimination and excretionÂ
Half-life:Â
Administration:Â
Clean the affected area and apply the required quantity of cream over it.Â
Avoid the usage of mometasone furoate over the groin, face, or armpitsÂ
Patient information leafletÂ
Generic Name: mometasone furoate Â
Why do we use mometasone furoate? Â
Mometasone furoate is used in the treatment of pain, infections of the skin, redness, itching, etc.Â